Ming Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ming Ni has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Han Chen
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publications - Liyong Zhong
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publications Alexandra Latini
Laboratorio de Bioenergética y Estrés Oxidativo, Departamento de Bioquímica, Centro de Ciencias Biológicas, Florianópolis, Brazil
1 shared publicationAlicia Inés Torres
Centro de Microscopía Electrónica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publication- Ana Lucía De Paul
Centro de Microscopía Electrónica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publication Carolina Leimgruber
Centro de Microscopía Electrónica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publication
Latest Publications
- 1 October 2022
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 29 (10) , X1
ERRATUM: Evidence of cellular senescence during the development of estrogen-induced pituitary tumors
"ERRATUM: Evidence of cellular senescence during the development of estrogen-induced pituitary tumors" published on 01 Oct 2022 by Bioscientifica Ltd.
- 1 October 2022
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 29 (10) , X1
ERRATUM: Evidence of cellular senescence during the development of estrogen-induced pituitary tumors
"ERRATUM: Evidence of cellular senescence during the development of estrogen-induced pituitary tumors" published on 01 Oct 2022 by Bioscientifica Ltd.
- 1 October 2022
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 29 (10) , 581-588
Precocious puberty due to intracranial germ cell tumors: a case–control study
Children with intracranial germ cell tumors may present premature sexual development via either GnRH-dependent cause or GnRH-independent cause. We conducted a single-center retrospective study on thirty-seven precocious puberty patients with intracranial germ cell tumors and twenty-five age-matched prepubertal patients with elevated human-chorionic-gonadotropin levels. Classification of precocious puberty was derived from human-chorionic-gonadotropin, gonadotropin, sex steroid levels and their changes. Five boys were assigned to GnRH-dependent group (G1). Thirty-one boys and one girl were assigned to GnRH-independent group (G2) with a median human-chorionic-gonadotropin of 76.75 (8.29-2747) IU/L. Seven boys and eighteen girls were conducted as controls, with a median human-chorionic-gonadotropin of 17.12 (2.91-1062) IU/L. Patients in G1 had constant pubertal LH and testosterone levels after tumor complete response. Patients in G2 had hCG levels that decreased simultaneously with testosterone/estradiol levels, prior to tumor regression. The differences in hCG levels and the gender ratio were significant between G2 and controls (p=0.006 and p<0.001, separately). Among intracranial germ cell tumor patients with positive human-chorionic-gonadotropin, boys with significantly higher human-chorionic-gonadotropin levels more easily developed precocious puberty. Our results suggest that, GnRH-independent precocious puberty commonly regress together with tumor regression. In comparison, results were inconclusive in tying tumor regression to the regression of GnRH-dependent PP.
- 1 October 2022
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 29 (10) , 581-588
Precocious puberty due to intracranial germ cell tumors: a case–control study
Children with intracranial germ cell tumors may present premature sexual development via either GnRH-dependent cause or GnRH-independent cause. We conducted a single-center retrospective study on thirty-seven precocious puberty patients with intracranial germ cell tumors and twenty-five age-matched prepubertal patients with elevated human-chorionic-gonadotropin levels. Classification of precocious puberty was derived from human-chorionic-gonadotropin, gonadotropin, sex steroid levels and their changes. Five boys were assigned to GnRH-dependent group (G1). Thirty-one boys and one girl were assigned to GnRH-independent group (G2) with a median human-chorionic-gonadotropin of 76.75 (8.29-2747) IU/L. Seven boys and eighteen girls were conducted as controls, with a median human-chorionic-gonadotropin of 17.12 (2.91-1062) IU/L. Patients in G1 had constant pubertal LH and testosterone levels after tumor complete response. Patients in G2 had hCG levels that decreased simultaneously with testosterone/estradiol levels, prior to tumor regression. The differences in hCG levels and the gender ratio were significant between G2 and controls (p=0.006 and p<0.001, separately). Among intracranial germ cell tumor patients with positive human-chorionic-gonadotropin, boys with significantly higher human-chorionic-gonadotropin levels more easily developed precocious puberty. Our results suggest that, GnRH-independent precocious puberty commonly regress together with tumor regression. In comparison, results were inconclusive in tying tumor regression to the regression of GnRH-dependent PP.
- Open Access
- 26 March 2022
- Published by Wiley in International Journal of Endocrinology
- Vol. 2022, 1-10
Pituitary Stalk Germ Cell Tumors: Retrospective Case Series and Literature Review
Objective. Intracranial germ cell tumors with isolated pituitary stalk involvement are rare. Early recognition and long-term monitoring deserve further exploration. Methods. A retrospective study reviewing eleven intracranial germ cell tumor patients with isolated pituitary stalk involvement was performed. Results. Seven boys and four girls who presented with a hyperintense pituitary stalk on postcontrast T1-weighted magnetic resonance imaging without a posterior pituitary signal were included. The average maximum width of the pituitary stalk was 5.2±1.6mm. Polydipsia and polyuria occurred in all patients, followed by growth retardation, fatigue, and amenorrhoea. Eight patients (72) had concomitant partial anterior pituitary hormone deficiency. Seven patients initially had elevated human chorionic gonadotropin levels. After chemoradiotherapy, ten patients attended follow-up. Central diabetes insipidus remained in all survivors, and four (40) of them had concomitant partial anterior pituitary hormone deficiency, primarily of growth hormone and insulin-like growth factor-1. The causes of the delayed diagnosis of previous studies were mainly negative tumor markers and the initial pathological diagnosis of autoimmune diseases. Conclusion. Isolated pituitary stalk lesions could be a signal of intracranial germ cell tumors, especially coexisting with diabetes insipidus, hypopituitarism, and a worse response to glucocorticoid therapy. Negative results of tumor markers and pathology could not exclude the diagnosis. Chemoradiotherapy is an effective therapy, leaving mild-t-moderate hypothalamus-pituitary dysfunction. This rare neuroimaging feature may be used as a factor to predict long-term neuroendocrine outcomes.
- 26 March 2022
- Published by Wiley in International Journal of Endocrinology
- Vol. 2022, 1-10
Open AccessPituitary Stalk Germ Cell Tumors: Retrospective Case Series and Literature Review
Objective. Intracranial germ cell tumors with isolated pituitary stalk involvement are rare. Early recognition and long-term monitoring deserve further exploration. Methods. A retrospective study reviewing eleven intracranial germ cell tumor patients with isolated pituitary stalk involvement was performed. Results. Seven boys and four girls who presented with a hyperintense pituitary stalk on postcontrast T1-weighted magnetic resonance imaging without a posterior pituitary signal were included. The average maximum width of the pituitary stalk was 5.2±1.6mm. Polydipsia and polyuria occurred in all patients, followed by growth retardation, fatigue, and amenorrhoea. Eight patients (72) had concomitant partial anterior pituitary hormone deficiency. Seven patients initially had elevated human chorionic gonadotropin levels. After chemoradiotherapy, ten patients attended follow-up. Central diabetes insipidus remained in all survivors, and four (40) of them had concomitant partial anterior pituitary hormone deficiency, primarily of growth hormone and insulin-like growth factor-1. The causes of the delayed diagnosis of previous studies were mainly negative tumor markers and the initial pathological diagnosis of autoimmune diseases. Conclusion. Isolated pituitary stalk lesions could be a signal of intracranial germ cell tumors, especially coexisting with diabetes insipidus, hypopituitarism, and a worse response to glucocorticoid therapy. Negative results of tumor markers and pathology could not exclude the diagnosis. Chemoradiotherapy is an effective therapy, leaving mild-t-moderate hypothalamus-pituitary dysfunction. This rare neuroimaging feature may be used as a factor to predict long-term neuroendocrine outcomes.